The Movement Disorder Society criteria for progressive supranuclear palsy define diagnostic allocations, stratified by certainty levels and clinical predominance types. We aimed to study the frequency of ambiguous multiple allocations and to develop rules to eliminate them
Background: The Movement Disorder Society criteria for progressive supranuclear palsy introduced the...
Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinson...
The phenotypic variability of progressive supranuclear palsy (PSP) may account for its frequent misd...
Background The Movement Disorder Society criteria for progressive supranuclear palsy define diagnost...
BACKGROUND: The Movement Disorder Society criteria for progressive supranuclear palsy define diagnos...
Background: The Movement Disorder Society diagnostic criteria for progressive supranuclear palsy int...
Recently, both the paper "Advances in progressive supranuclear palsy: new diagnostic criteria, bioma...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
BackgroundPSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publish...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
The International Parkinson Disease and Movement Disorder Society PSP study group (IPMDS-PSP) recent...
Background: The Movement Disorder Society criteria for progressive supranuclear palsy introduced th...
BackgroundThe Movement Disorder Society criteria for progressive supranuclear palsy introduced the c...
Background: The Movement Disorder Society criteria for progressive supranuclear palsy introduced the...
Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinson...
The phenotypic variability of progressive supranuclear palsy (PSP) may account for its frequent misd...
Background The Movement Disorder Society criteria for progressive supranuclear palsy define diagnost...
BACKGROUND: The Movement Disorder Society criteria for progressive supranuclear palsy define diagnos...
Background: The Movement Disorder Society diagnostic criteria for progressive supranuclear palsy int...
Recently, both the paper "Advances in progressive supranuclear palsy: new diagnostic criteria, bioma...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
BackgroundPSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publish...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
The International Parkinson Disease and Movement Disorder Society PSP study group (IPMDS-PSP) recent...
Background: The Movement Disorder Society criteria for progressive supranuclear palsy introduced th...
BackgroundThe Movement Disorder Society criteria for progressive supranuclear palsy introduced the c...
Background: The Movement Disorder Society criteria for progressive supranuclear palsy introduced the...
Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinson...
The phenotypic variability of progressive supranuclear palsy (PSP) may account for its frequent misd...